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MaBACKGROUND In severely symptomatic patients with obstructive hypertrophic cardiomyopathy (HCM) and mild septal
hypertrophy, mitral valve (MV) abnormalities may play an important role in MV displacement into the left ventricular (LV)
outﬂow tract. Therefore, isolated myectomy may not relieve outﬂow obstruction and symptoms, and MV replacement is
often the surgical alternative.
OBJECTIVES This study sought to assess the clinical and hemodynamic results of cutting thickened secondary MV
chordae combined with a shallow septal muscular resection in severely symptomatic patients with obstructive HCM and
mild septal hypertrophy.
METHODS Clinical features were compared before surgery and at most recent clinical evaluation in 39 consecutive
patients with obstructive HCM.
RESULTS Over a 23  2 months follow-up, New York Heart Association functional class decreased from 2.9  0.5
pre-operatively to 1.1  1.1 post-operatively (p < 0.001), with no patient in class III at most recent evaluation. The
resting outﬂow gradient decreased from 82  43 mm Hg to 9  5 mm Hg (p < 0.001) and septal thickness decreased
from 17  1 mm to 14  2 mm (p < 0.001). No patient had MV prolapse or ﬂail and 1 had residual moderate-to-severe
MV regurgitation at most recent evaluation. MV geometry before and after surgery was compared with that of
25 consecutive patients with similar clinical proﬁle and septal thickness that underwent isolated myectomy. After
adjustment for differences in pre-operative values between the groups, the post-operative anterior MV leaﬂet-
annulus ratio was 17% greater and tenting area 24% smaller in patients with chordal cutting, indicating that MV
apparatus had moved to a more normal posterior position within the LV cavity, preventing MV systolic displacement
into the outﬂow tract and outﬂow obstruction.
CONCLUSIONS This procedure relieves heart failure symptoms, abolishes LV outﬂow gradient, and avoids MV
replacement in patients with obstructive HCM and mild septal thickness. (J Am Coll Cardiol 2015;66:1687–96)
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ABBR EV I A T I ON S
AND ACRONYMS
AML = anterior mitral leaﬂet
HCM = hypertrophic
cardiomyopathy
LV = left ventricular
MV = mitral valve
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1688(MV) systolic anterior motion, the most
favorable results have been obtained in pa-
tients with marked septal hypertrophy (4–6).
However, a sizable minority of HCM pa-
tients with signiﬁcant LV outﬂow gradients
has relatively mild septal hypertrophy, which
can make it technically difﬁcult to achieve an
adequate reduction in muscle thickness (4,7).Such patients commonly have abnormalities of the
MV apparatus, which contribute importantly to LV
outﬂow obstruction (8–12), and they often undergo
MV replacement as an alternative to septal myectomy
(4,7,11,12). These technical difﬁculties in HCM pa-
tients with mild septal hypertrophy have stimulated
the search for novel operative approaches, including
transaortic extension or plication of the anterior
mitral leaﬂet (AML) (13–16), for the purpose of avoid-
ing MV replacement and the complications associated
with prosthetic valves.SEE PAGE 1697In the present study, we report the results of a
novel operative procedure using transaortic cutting
of thickened MV secondary chordae. We performed
this procedure in association with a shallow septal
muscular resection (myectomy) to abolish the LV
outﬂow gradient, relieve symptoms, and avoid MV
replacement in a consecutive cohort of patients with
obstructive HCM, mild septal thickness, and drug
refractory symptoms.
METHODS
STUDY POPULATION. Between February 2000 and
December 2013, a total of 268 consecutive patients
with obstructive HCM underwent a surgical myec-
tomy performed by the same surgeon (P.F.) at the
participating institutions. In the present study, we
report the clinical results in each of the 39 HCM pa-
tients who, between January 2011 and December 2013,
underwent cutting of MV secondary chordae com-
bined with a shallow septal myectomy because the
magnitude and distribution of septal hypertrophy
was judged inadequate for a classic extended myec-
tomy (6). Each of these 39 patients had a LV outﬂow
gradient $50 mm Hg at rest or with physiologic
provocation, disabling symptoms unresponsive to
medical therapy, and septal thickness #19 mm. These
39 patients include all patients with obstructive HCM
and mild septal thickness (#19 mm) who had surgery
for relief of the LV outﬂow gradient performed be-
tween January 2011 and December 2013. Our institu-
tional review committees approved this study. All
study patients were fully informed of the natureand risks of their condition, the standard therapies
currently used to treat it, as well as the innovative
nature of the surgical procedure they were offered,
and gave written informed consent.
ECHOCARDIOGRAPHY. The criteria used in the pres-
ent investigation for the diagnosis of HCM have
been previously reported (17,18). Standard echocar-
diographic measurements were assessed before my-
ectomy operation and at the most recent clinical
evaluation, as previously described (17). The LV
outﬂow tract gradient was measured under resting
conditions and with physiological provocation. The
degree of MV regurgitation was assessed using mul-
tiple Doppler echocardiographic criteria, including jet
area, jet width, and spectral Doppler intensity, and
was graded on a scale from 0 to 4 (0 ¼ none, 1 ¼mild;
2 ¼ moderate; 3 ¼ moderate to severe; and 4 ¼ se-
vere) (4,19).
SURGICAL PROCEDURE. The papillary muscles were
mobilized and a septal muscular resection (myec-
tomy) was performed as previously described (17).
Because the patients included in the present study
had mild septal thickness, the septal resection was
shallow. After papillary muscle mobilization and
septal resection, the ventricular surface of the AML
was examined to decide which secondary chordae to
cut. This decision was made on the basis of intra-
operative transesophageal echocardiographic assess-
ment and direct surgical inspection of the anatomic
and functional features of the MV apparatus. We have
used the term secondary chordae (i.e., secondary or-
der chordae) to describe all anterior leaﬂet chordae
(including strut chordae) that insert beyond the free
margin and rough zone of the leaﬂet (Figure 1A)
(20,21). Those ﬁbrotic secondary chordae judged to
play an important role in tethering the AML toward
the LV outﬂow tract and ventricular apex were cut
selectively. The number of resected chordae varied in
relation to the anatomical features of the chordal
apparatus in the individual patient; resected chordae
were particularly thickened, often agglutinated, and
usually connected to a ﬁbrotic area of the corre-
sponding papillary muscle.
The leaﬂet was pushed toward the left atrium using
2 forceps to identify the retracted secondary chordae
and the lines of traction exercised by the retracted
chordae on the anterior leaﬂet. The identiﬁed sec-
ondary chordae were then selected with a nerve
hook (Figure 1B). The corresponding primary chordae
(located in front of the secondary chordae) were also
identiﬁed to conﬁrm that primary chordae were sup-
porting the free margin of the anterior leaﬂet. In most
of our study patients, the abnormal traction exerted
FIGURE 1 Transaortic Chordal Cutting in Obstructive HCM
(A) Schematic illustration of the insertion of the primary and secondary chordae on the
ventricular surface of the anterior mitral valve (MV) leaﬂet. The primary chordae are
inserted on the leaﬂet free edge. The secondary chordae are inserted on the leaﬂet body.
In patients with obstructive hypertrophic cardiomyopathy (HCM), the secondary chordae
may be ﬁbrotic and retracted, thereby increasing chordal slack. (B) Intraoperative
photograph obtained at the time of transaortic secondary chordal cutting in a patient with
obstructive HCM. A thickened secondary chordal structure is exposed using a nerve hook,
and scissors (on the left) are ready to cut this structure. Other chordal structures are
pulled aside by a second nerve hook. See Online Video 1.
FIGURE 2 Echocardiographic Measurements of MV Geometry in a
Patient With Obstructive HCM
Measurements are obtained at the onset of systole. The anterior mitral
leaﬂet-annulus ratio is calculated as the ratio between anterior MV leaﬂet
projection on annulus plane (X) and annulus length (A1–A2). The tenting area
(TA) comprises the area between MV leaﬂets and the annulus plane. The
arrow on the top left indicates the phase of the cardiac cycle. Ao ¼ aorta;
C-p ¼ coaptation point; LV ¼ left ventricle; other abbreviations as in Figure 1.
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1689by the secondary chordae on the papillary muscle was
conﬁrmed by the presence of ﬁbrosis at the site of
attachment of the chordae to the papillary muscle.
The distal extreme of the ﬁbrotic secondary chordae
were then cut from their connection to the papillary
muscle and the proximal extreme was cut from the
ventricular surface of the AML (Online Video 1). In
some patients, overgrown ﬁbrotic tissue was attached
to the proximal extreme and ventricular surface of the
severed secondary chordae. When present, this over-
grown tissue was removed together with the chordae
in order to increase leaﬂet mobility (Online Video 1).
To prevent lesions of the leaﬂet body, great caution
was used in disconnecting the secondary chordae
from the leaﬂet.
SECONDARYCHORDAL CUTTING VERSUS CONVENTIONAL
SURGICAL TECHNIQUES. Between February 2000 and
December 2010, a total of 29 consecutive severely
symptomatic patients with obstructive HCM and mild
septal thickness (#19 mm) underwent surgery for re-
lief of LV outﬂow gradient without associated chordal
cutting. Clinical and hemodynamic results in our 39
study patients with chordal cutting were compared
with those in this group of 29 patients without chordal
cutting to investigate the potential advantages of our
novel operational technique over conventional sur-
gery for relief of LV outﬂow gradient.
ASSESSMENT OF THE EFFECTS OF SECONDARY CHORDAL
CUTTING ON MV GEOMETRY AND FUNCTION. To inves-
tigate the effects of secondary chordal cutting on MV
geometry and function, echocardiographic indexes
that measure the position of the MV coaptation point
in the LV cavity were obtained in the 39 study pa-
tients with chordal cutting. These measurements
were compared with measurements obtained in 25 of
the 29 patients with obstructive HCM and mild septal
thickness who had undergone a conventional septal
myectomy without chordal cutting. Four patients in
the group without chordal cutting were excluded
from this analysis because they had undergone septal
myectomy with associated MV repair and insertion of
a prosthetic ring or MV replacement.
Two echocardiographic indexes of the displace-
ment of the MV coaptation point in the LV cavity were
obtained before and after surgery in the parasternal
long-axis view at the onset of systole and were
compared between the 39 study patients with chordal
cutting and the 25 patients with isolated septal
myectomy (Figure 2). Displacement of the coaptation
point in the outﬂow tract was assessed as the ratio
between the AML projection on the mitral annulus
plane and annulus length, and expressed as AML-
annulus ratio (22). Displacement of the coaptation
point toward the LV apex was assessed as the area
TABLE 1
Evaluatio
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1690enclosed between the valve leaﬂets and annulus
plane, and expressed as MV tenting area (23).
STATISTICAL ANALYSES. Primary analyses were
aimed at describing and comparing pre-operative and
post-operative clinical characteristics of the 39
patients with secondary chordal cutting associated
with myectomy. Variables were presented as means
with standard deviations, or frequencies with pro-
portions; differences between pre-operative and
post-operative values were assessed for statistical
signiﬁcance using the paired Student t test, chi-square
test for trend, Wilcoxon signed rank test for paired
data, or Fisher exact test, as appropriate. The changes
observed after surgery in the AML-annulus ratio and
MV tenting area in the 39 patients with chordal cutting
associated with myectomy were compared with those
observed in the 25 patients with isolated myectomy
using the standard analysis of covariance, with
post-operative values as the dependent variable and
pre-operative values as covariates. Relationships
between variables were determined by Pearson or
Spearman r correlation coefﬁcients. Values of p < 0.05
were considered statistically signiﬁcant. Computa-
tions were performed with IBM SPSS 19.0 statistical
software (SPSS, Inc., Chicago, Illinois).
RESULTS
OUTCOME AFTER SURGERY IN PATIENTSWITH CHORDAL
CUTTING. The baseline clinical characteristics and theClinical Characteristics Before Surgery and at Most Recent
n in 39 HCM Patients With Secondary Chordal Cutting and a
eptal Myectomy
Before Surgery
Most Recent
Evaluation p Value
ctional class <0.001*
0 34 (87)
7 (18) 5 (13)
32 (82) 0
llation 13 (33) 6 (15)
graphic data
adient at rest, mm Hg 82  43 9  5 <0.001
ptal thickness, mm 17  1 14  2 <0.001
mm 40  7 42  5 0.085
68  6 63  5 <0.001
ial diameter, mm 49  6 45  7 <0.001
alve regurgitation grade <0.001*
17 (44) 33 (85)
13 (33) 5 (13)
7 (18) 1 (3)
2 (5) 0
(%) or mean  SD. *Wilcoxon signed rank test for paired data.
left ventricular end-diastolic dimension; LVEF ¼ left ventricular ejection fraction;
ventricular outﬂow tract; NYHA ¼ New York Heart Association.hemodynamic and clinical outcomes in the 39 study
patients with chordal cutting are summarized in
Table 1. Duration of follow-up was 23  2 months
(median 24 months) and was $6 months in each pa-
tient. None of the study patients died during hospi-
talization or follow-up, and none required MV
replacement.
Cl in i ca l and hemodynamic beneﬁ t . Each of the
39 patients with chordal cutting experienced sub-
stantial symptomatic and hemodynamic improve-
ment after surgery. Pre-operatively, 32 (82%) patients
were severely symptomatic in New York Heart Asso-
ciation functional class III or IV, and 7 (18%) were in
class II. Post-operatively, 34 (87%) were asymptom-
atic in New York Heart Association functional class I,
and 5 (13%) were in class II (p < 0.001) (Figure 3A).
Peak LV outﬂow gradient at rest was 82  43 mm Hg
(median 75 mm Hg) pre-operatively and 9  5 mm Hg
(median 10 mm Hg) post-operatively (p < 0.001),
with an outﬂow gradient <15 mm Hg in 34 (87%)
patients at the most recent evaluation (Figure 3B).
The left atrial diameter was 49  6 mm before sur-
gery and 45  7 mm at the most recent evaluation
(p < 0.001). Septal thickness was 17  1 mm (median
17 mm) before surgery and 14  2 mm (median
14 mm) after surgery (p < 0.001), indicative of a
shallow myectomy.
A median of 3 chordae (up to a maximum of 8) was
cut in each patient. None of the 39 study patients had
MV prolapse or valve ﬂail before surgery or at the
most recent evaluation. Of the 9 study patients
with grade 3 or 4 MV regurgitation before surgery, 8
had lower grades of MV regurgitation after surgery,
whereas 1 patient had persistent moderate-severe MV
regurgitation post-operatively.
Of the 39 study patients, 13 had atrial ﬁbrillation
before surgery (paroxysmal in 6, persistent in 6, and
permanent in 1 patient). Of these 13 patients, 10 un-
derwent pulmonary vein isolation using radio-
frequency ablation at the time of the myectomy
operation; 7 of these 10 patients were in sinus rhythm
at most recent evaluation.
ADVANTAGES OF CHORDAL CUTTING OVER
CONVENTIONAL SURGERY FOR OUTFLOW GRADIENT
RELIEF. While none of the 39 study patients with
chordal cutting associated with a shallow septal
myectomy died during hospitalization or follow-up,
and none required MV repair with insertion of a
prosthetic ring or MV replacement, 1 of the 29 patients
with a conventional septal myectomy and without
chordal cutting died during hospitalization due to
respiratory complications and renal failure, 3 required
MV repair with insertion of a prosthetic ring, and 1
FIGURE 3 Clinical and Hemodynamic Results of MV Chordal Cutting Associated With a Shallow Myectomy
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(A) New York Heart Association functional class and (B) left ventricular outﬂow gradient at rest, pre-operatively, and at the most recent
evaluation, in 39 study patients with obstructive hypertrophic cardiomyopathy, secondary chordal cutting, and a shallow septal myectomy.
Mean values (red dots) are presented with standard deviations (length of the vertical line).
TABLE 2 Comparison of Intraoperative Results and Clinical Outcome in HCM Patients
With and Without Chordal Cutting
Patients
With Chordal
Cutting (n ¼ 39)
Patients
Without Chordal
Cutting (n ¼ 29) p Value
Age, yrs 58  13 55  15 0.535
Number of in-hospital/follow-up deaths None 1 (3) 0.426*
Number of MV repair/replacement None 4 (14) 0.029*
Number of cut chordae 1–8 (3) —
Clinical features at most recent evaluation
NYHA functional class III–IV None 3 (11) 0.068*
Residual LVOT gradient $30 mm Hg None 2 (7) 0.171*
Post-operative LVOT gradient, mm Hg 9  5 13  10 0.041
Post-operative LVEF, % 63  5 65  7 0.193
Mitral valve regurgitation grade $3 1 (3) 3 (11) 0.301*
Values are n, mean  SD, n (%), or range (median). *Fisher exact test.
HCM ¼ hypertrophic cardiomyopathy; MV ¼ mitral valve; other abbreviations as in Table 1.
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1691required MV replacement. Clinical and hemodynamic
results in the patients with or without chordal cutting
are summarized in Table 2.
MECHANISM BYWHICH CHORDAL CUTTING REDUCES LV
OUTFLOWGRADIENT. The differences in the geometry
of the MV apparatus before and after surgery in the
39 study patients with chordal cutting and a shallow
myectomy, and the 25 patients with isolated myec-
tomy and without chordal cutting, are summarized in
Table 3 and illustrated in Figures 4 and 5, and Online
Videos 2 and 3.
AML-annulus rat io . In the patients with chordal
cutting, the AML-annulus ratio increased signiﬁ-
cantly after surgery compared to pre-operative
values, from 0.45  0.08 to 0.57  0.08 (p < 0.001),
a 27% increase. This indicates that the leaﬂet coap-
tation point was repositioned more normally; closer
to the posterior LV wall and farther from the outﬂow
tract, with a consequent increase in the LV outﬂow
tract size (Table 3, Figures 4A, 4B, and 5A, Online
Videos 2 and 3). This increase in the post-operative
AML-annulus ratio showed a moderate variability
and, in absolute terms, appeared to be relatively
constant (Figure 5A).
In the patients without chordal cutting, the AML-
annulus ratio changed slightly, but signiﬁcantly,
after surgery, from 0.49  0.08 to 0.51  0.08
(p ¼ 0.003), a 3% increase (Figures 4C, 4D, and 5A).
After adjustment for the differences in pre-operative
values between patients with and without chordalcutting, the difference between the mean post-
operative values was þ0.09 (SE: 0.01; p < 0.001),
representing a 17% greater post-operative AML-
annulus ratio in patients with chordal cutting
compared with controls.
MV tent ing area . In patients with chordal cutting,
the MV tenting area decreased signiﬁcantly after
surgery compared with pre-operative values, from
2.14  0.62 cm2 to 1.51  0.54 cm2 (p < 0.001), a 29%
decrease. This indicates a reduction in the systolic
displacement of the mitral leaﬂets toward the apex
TABLE 3 Geometry of the MV Apparatus Before and After Surgical Myectomy in 39 HCM Patients With and 25 Without Chordal Cutting
Patients With
Chordal Cutting
(Mean  SD)
Patients Without
Chordal Cutting
(Mean  SD)
Crude Post-Operative
Difference Between Groups
(mean  SE)
Adjusted Post-Operative
Difference Between Groups*
(mean  SE) p Value
AML-annulus ratio
Pre-operative value 0.45  0.08 0.49  0.08
Post-operative value 0.57  0.08 0.51  0.08 þ0.06  0.02 þ0.09  0.01 <0.001
Absolute change þ0.11  0.07 –0.01  0.02
p value <0.001 0.003
Proportional change þ27% þ3% þ17%
MV tenting area, cm2
Pre-operative value 2.14  0.62 1.78  0.48
Post-operative value 1.51  0.54 1.70  0.41 –0.19  0.13 –0.42  0.10 <0.001
Absolute change, cm2 –0.63  0.42 –0.08  0.27
p value <0.001 0.172
Proportional change –29% –4% –24%
*Difference between post-operative mean values, after adjustment for differences in pre-operative values between the groups using the analysis of covariance.
AML ¼ anterior mitral leaﬂet.
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1692(Table 3, Figures 4A and 4B). This decrease in post-
operative MV tenting area showed an important
variability and was more marked in patients with a
larger pre-operative tenting area (Figure 5B).FIGURE 4 Echocardiographic Images Showing the Effects of Second
Pre-operative (A) and post-operative (B) echocardiographic images obta
thickness. After secondary chordal cutting (5 chordae) and a shallow se
thickened secondary chordae is abolished (arrows), the MV apparatus h
normal position in the LV cavity, and the MV tenting area is substantially
(C) and post-operative (D) echocardiographic images obtained in early s
thickness, and isolated septal myectomy without secondary chordal cut
from 2.70 to 2.65 cm2. Abbreviations as in Figures 1 and 2.In the patients without chordal cutting, the
MV tenting area did not change signiﬁcantly after
surgery, from 1.78  0.48 cm2 to 1.70  0.41 cm2
(p ¼ 0.172) (Figures 4C and 4D). After adjustmentary Chordal Cutting on the MV Apparatus in Obstructive HCM
ined in early systole in a patient with obstructive HCM and mild septal
ptal myectomy, the abnormal tethering of the anterior leaﬂet by
as moved away from the LV outﬂow tract to a more posterior and
reduced, from 3.5 to 2.2 cm2. See Online Videos 2 and 3. Pre-operative
ystole in a patient with obstructive HCM, relatively mild septal
ting. After surgery, the MV TA remained substantially unchanged,
FIGURE 5 Scatterplots of Pre-Operative and Post-Operative Echocardiographic
Measurements of MV Geometry in 39 Patients With and 25 Patients Without
Chordal Cutting
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(A) Anterior mitral leaﬂet (AML)-annulus ratio and (B) MV TA. Abbreviations as in
Figures 1 and 2.
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1693for the differences in pre-operative values between
the 2 patient groups, the difference between the
means was –0.42 cm2 (SE: 0.10; p < 0.001), repre-
senting a 24% smaller post-operative MV tenting
area in patients with chordal cutting compared with
controls.
DISCUSSION
The results of the present study show that our novel
transaortic surgical procedure of cutting ﬁbrotic and
retracted MV secondary chordae (in combination with
a shallow septal myectomy) can abolish or substan-
tially reduce the LV outﬂow gradient, relieve heart
failure symptoms, and improve quality of life in pa-
tients with obstructive HCM and mild septal thick-
ness. This procedure may also reduce the risk of
iatrogenic septal defect and avoid MV replacement
(4,7,24).
In each of our study patients with transaortic
chordal cutting associated with a shallow myectomy,
functional limitation decreased to class I or II and LV
outﬂow gradient was abolished or substantially
reduced after surgery. In the great majority of the
study patients, moderate or severe MV regurgitation
either decreased by at least 1 grade (to grade 1 to 2), or
was abolished after surgery. None of the study pa-
tients required MV repair through the left atrium or
MV replacement, and none had MV ﬂail or prolapse at
the most recent evaluation.
Our ﬁndings also clarify the mechanism by which
this transaortic procedure led to substantial clinical
and hemodynamic improvement in our study pa-
tients. In normal subjects, the secondary chordae
(inserted on the body of the MV leaﬂet ventricular
surface) help to preserve ventricular shape and
function during ejection, while the primary chordae
(inserted on the leaﬂet free edge) prevent valve ﬂail
and regurgitation by opposing the valve closing
forces in systole (25,26). However, in patients with
obstructive HCM, the secondary chordae of the
anterior MV leaﬂet often appear thickened and
retracted at surgery or necropsy (8,11). The effects
of these chordal abnormalities on the MV apparatus
have not been previously investigated. However,
earlier studies have shown that in patients with
obstructive HCM, remodeling of the left ventricle
and MV apparatus increases leaﬂet and chordal
slack, thereby exposing the tip of the anterior
leaﬂet to the risk of being displaced into the outﬂow
tract by blood ﬂow drag forces during ejection
(8–11,27–31).
The rationale for our novel operative approach
relied on the hypothesis that, in many patients withobstructive HCM and mild septal thickness, ﬁbrotic
and retracted secondary chordae may cause abnormal
tethering of the AML and favor the displacement of
slack portions of the leaﬂet (and attached primary
chordae) into the LV outﬂow tract and the ejection
ﬂow. The results of our study show that in this patient
subset, secondary chordal cutting in association with
a shallow myectomy moves the MV coaptation point
away from the LV outﬂow tract to a more posterior
CENTRAL ILLUSTRATION Secondary Chordal Cutting in Obstructive
HCM: Effects of Secondary Chordal Cutting on the Geometry and
Function of the MV Apparatus
Primary 
Chordae
Fibrotic
Secondary
Chordae
A. Pre-operative
C. Post-operative
without chordal cutting
B. Post-operative
with chordal cutting
LV
LA
Ao
Ferrazzi, P. et al. J Am Coll Cardiol. 2015; 66(15):1687–96.
(A) In patients with obstructive hypertrophic cardiomyopathy (HCM), ﬁbrotic and retrac-
ted mitral valve (MV) secondary chordae contribute to displace the body of the anterior
leaﬂet into the left ventricular outﬂow tract. (B) Cutting selected abnormal chordae (in
combination with a shallow septal myectomy) moves the MV apparatus and leaﬂet
coaptation point away from the outﬂow tract to a more posterior and normal position in
the left ventricular cavity, substantially increasing outﬂow tract size and decreasing MV
tenting area. (C) Isolated septal myectomy (i.e., without associated chordal cutting) does
not alter the anterior displacement of the MV apparatus. Ao ¼ aorta; LA ¼ left atrium;
LV ¼ left ventricle.
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1694and normal position within the LV cavity by reducing
anterior leaﬂet tethering and restoring slack primary
chordae to their function. These changes in MV ge-
ometry and function enlarge the outﬂow tract, pre-
vent displacement of the MV apparatus into the
path of the ejection ﬂow, and contribute to abolition
of LV outﬂow obstruction (Central Illustration, Online
Videos 2 and 3).
The extent of MV repositioning in the LV cavity
after chordal cutting varied among our study pa-
tients. In particular, the post-operative decrease in
MV tenting area tended to be more marked in patients
with a larger pre-operative tenting area. It is likely
that several morphologic features that affect the
MV position in the LV cavity of patients with HCM
contributed to this variability, including the extent of
anterior and apical papillary muscle displacement in
the cavity, the severity of MV and chordal abnor-
malities, and variability in the impact of early systolic
ﬂow on the posterior leaﬂet (8–11,27–32).
Although secondary chordal cutting has previously
been used to reduce systolic tethering of the AML and
valve regurgitation in patients with ischemic dilated
cardiomyopathy and severe MV insufﬁciency (33),
this operative strategy remains controversial because
the secondary chordal function of maintaining ven-
tricular geometry and enhancing wall thickening may
be helpful in the presence of LV dilation and systolic
dysfunction (26). However, in patients with obstruc-
tive HCM, these potentially unfavorable effects of
secondary chordal cutting are prevented by the pre-
served or hyperdynamic systolic function and small
LV cavity.
We must underline that although chordal cutting
may improve operative results in patients with
obstructive HCM andmild LV hypertrophy undergoing
a shallow septal myectomy, this operation requires
surgeons with particular experience with the anatomy
of obstructive HCM. Therefore, our observations sup-
port the recommendations of the American College of
Cardiology Foundation/American Heart Association
HCM guidelines that operator and institutional expe-
riencewith surgicalmanagement of patientswithHCM
are key determinants of a successful outcome (34).
STUDY LIMITATIONS. In the present study, the only
criteria used to select patients for secondary chordal
cutting were presence of LV outﬂow gradient $50 mm
Hg at rest or with provocation, relatively mild septal
thickness (#19 mm), and disabling symptoms unre-
sponsive to medical therapy. We selected this sub-
group because it is in patients with obstructive HCM
and only mild septal hypertrophy that abnormalities
of the mitral valve apparatus may play a particularly
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: Fibrotic and
retracted secondary MV chordae play an important role in systolic
displacement of the MV apparatus into the LV outﬂow tract in
patients with obstructive HCM, mild septal hypertrophy, and
drug-refractory symptoms. Transaortic cutting of ﬁbrotic sec-
ondary chordae, associated with a shallow myectomy, moves the
leaﬂet coaptation point away from the septum to a more posterior
position within the LV cavity, thereby enlarging the outﬂow tract,
preventing displacement of the MV leaﬂets into the path of
ejection ﬂow, abolishing outﬂow obstruction, and reducing the
need for deep muscular resection in this difﬁcult patient subset.
TRANSLATIONAL OUTLOOK: Further studies are needed to
enhance the pre-operative identiﬁcation of patients who may
beneﬁt from this transaortic approach and assess the long-term
durability of beneﬁt in severely symptomatic patients with
obstructive HCM and mild septal thickening.
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1695important role in generating the LV outﬂow gradient.
However, the extent of mitral valve repositioning in
the LV cavity after surgery in patients with chordal
cutting showed some variability. Therefore, a larger
and morphologically more diverse study population,
including patients with more marked LV hypertro-
phy, will be required to identify additional criteria
that could help to clarify which patients with
obstructive HCM may beneﬁt most from combining
secondary chordal cutting with septal myectomy.
CONCLUSIONS
We report the results of a novel operative procedure
using transaortic cutting of thickened MV secondary
chordae that, in association with a shallow myec-
tomy, moves the leaﬂet coaptation point away
from the septum to a more posterior position within
the LV cavity, increases LV outﬂow tract size, abol-
ishes or substantially decreases the LV outﬂow
gradient, relieves heart failure symptoms, and may
reduce the need for MV replacement in this im-
portant patient subset with obstructive HCM, drug
refractory symptoms, and relatively mild septal
thickness.
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